SecSonar.com

Allarity Therapeutics, Inc. (ALLR)

Allarity Therapeutics, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Allarity Therapeutics, Inc. (ALLR) is a Biotechnology company based in US with a market capitalization of $26M. Free cash flow was negative at -$14.8M. This page tracks ALLR's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 6 employees · IPO Dec 21, 2021

Valuation

Valuation & price

$1.35 · as of May 17, 2026 · -31.5% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

2.65

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$1.97$1.41$0.84Jul 25Dec 25Jul 26Jul 7, 25$0.98Jul 9, 25$1.05Jul 11, 25$1.01Jul 15, 25$1.01Jul 17, 25$1.00Jul 21, 25$0.97Jul 23, 25$1.13Jul 25, 25$1.02Jul 29, 25$1.06Jul 31, 25$1.04Aug 4, 25$1.01Aug 6, 25$1.01Aug 11, 25$0.95Aug 13, 25$1.00Aug 15, 25$0.96Aug 19, 25$0.91Aug 21, 25$0.88Aug 25, 25$0.94Aug 27, 25$1.59Aug 29, 25$1.54Sep 3, 25$1.82Sep 5, 25$1.97Sep 9, 25$1.88Sep 11, 25$1.86Sep 16, 25$1.52Sep 18, 25$1.58Sep 22, 25$1.78Sep 24, 25$1.63Sep 26, 25$1.58Sep 30, 25$1.58Oct 2, 25$1.62Oct 6, 25$1.65Oct 8, 25$1.70Oct 10, 25$1.61Oct 14, 25$1.52Oct 16, 25$1.45Oct 21, 25$1.48Oct 23, 25$1.39Oct 27, 25$1.34Oct 29, 25$1.42Oct 31, 25$1.45Nov 4, 25$1.23Nov 6, 25$1.11Nov 10, 25$1.22Nov 12, 25$1.27Nov 14, 25$1.18Nov 18, 25$1.14Nov 20, 25$0.99Nov 25, 25$1.18Nov 28, 25$1.33Dec 2, 25$1.20Dec 4, 25$1.16Dec 8, 25$1.16Dec 10, 25$1.17Dec 12, 25$1.14Dec 16, 25$1.07Dec 18, 25$1.02Dec 22, 25$0.98Dec 24, 25$1.05Dec 29, 25$1.05Jan 2, 26$1.14Jan 6, 26$1.11Jan 8, 26$1.19Jan 12, 26$1.14Jan 14, 26$1.21Jan 16, 26$1.18Jan 21, 26$1.18Jan 23, 26$1.20Jan 27, 26$1.20Jan 29, 26$1.05Feb 2, 26$0.96Feb 4, 26$0.84Feb 9, 26$0.84Feb 11, 26$0.90Feb 13, 26$0.85Feb 18, 26$0.90Feb 20, 26$0.92Feb 24, 26$0.95Feb 26, 26$0.99Mar 2, 26$0.99Mar 4, 26$1.05Mar 6, 26$1.24Mar 10, 26$1.27Mar 12, 26$1.35Mar 17, 26$1.25Mar 19, 26$1.10Mar 23, 26$1.14Mar 25, 26$1.12Mar 27, 26$1.07Mar 31, 26$1.09Apr 2, 26$1.16Apr 7, 26$1.16Apr 9, 26$1.15Apr 13, 26$1.19Apr 15, 26$1.25Apr 17, 26$1.23Apr 22, 26$1.40Apr 24, 26$1.34Apr 28, 26$1.37Apr 30, 26$1.35May 4, 26$1.25May 6, 26$1.48May 8, 26$1.55May 12, 26$1.52May 14, 26$1.51May 18, 26$1.43May 20, 26$1.49May 22, 26$1.77May 28, 26$1.67Jun 1, 26$1.72Jun 3, 26$1.58Jun 5, 26$1.61Jun 9, 26$1.61Jun 11, 26$1.55Jun 15, 26$1.48Jun 17, 26$1.34Jun 22, 26$1.36Jun 24, 26$1.30Jun 26, 26$1.30Jul 2, 26$1.29
$0.8152-week range$1.97
Loading valuation history…

Fundamentals

Key fundamentals

$26M

Market cap

—

Revenue growth (YoY)

100.0%

Gross margin

-$14.8M

Free cash flow (USD)

-$13.3M

Net debt

Net cash position

794.8%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$143.3KFY 2017$1.5MFY 2018$1.5MFY 2019$120.0KFY 2020$0.00FY 2021$0.00FY 2022$0.00FY 2023$0.00FY 2024$0.00FY 2025$320.0K
$143.3K$320K

Free cash flow by year

2016 → 2025

FY 2016$-4.1MFY 2017$-1.3MFY 2018$-4.2MFY 2019$-10.1MFY 2020$-7.3MFY 2021$-15.1MFY 2022$-16.8MFY 2023$-12.7MFY 2024$-17.6MFY 2025$-14.8M
-$4.1M-$14.8M

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 15, 2026 (EPS $-0.17)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJul 1, 2026Filing
  • 8-K eventTrial Presentation AnnouncementJun 22, 2026Filing
  • 8-K eventManagement Services AgreementJun 2, 2026Filing
  • Quarterly report10-Q FiledMay 15, 2026Filing
  • 8-K eventCompany PresentationMay 8, 2026Filing
  • 8-K eventManufacturing Campaign UpdateMay 6, 2026Filing
  • 8-K eventPatent Notice of AllowanceApr 28, 2026Filing
  • FinancingSecurities RegistrationApr 24, 2026Filing
  • 8-K eventScientific Posters PresentedApr 22, 2026Filing
  • 8-K eventEarnings ReleaseApr 1, 2026Filing

Questions

Frequently asked questions

What is Allarity Therapeutics, Inc.'s market cap?

Allarity Therapeutics, Inc. (ALLR) has a market capitalization of $26M.

What is ALLR's P/E ratio?

A meaningful P/E ratio is not available for ALLR — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is ALLR's price-to-book (P/B) ratio?

ALLR trades at 2.65 times book value per share.

When did Allarity Therapeutics, Inc. last report earnings?

ALLR last reported earnings on May 15, 2026; the next date is not yet scheduled.

Are insiders buying ALLR stock?

SEC Form 4 filings show no open-market insider buys at Allarity Therapeutics, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

EVAX

Evaxion Biotech A/S

$25.8M

SNTI

Senti Biosciences, Inc.

$25.5M

DYAI

Dyadic International, Inc.

$27.9M

BRNS

Barinthus Biotherapeutics plc

$27.9M

CELU

Celularity Inc.

$23.6M

IGC

IGC Pharma, Inc.

$28.7M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.